158 related articles for article (PubMed ID: 23135895)
1. Long term survival after trimodal therapy in malignant pleural mesothelioma.
Fahrner R; Ochsenbein A; Schmid RA; Carboni GL
Swiss Med Wkly; 2012; 142():w13686. PubMed ID: 23135895
[TBL] [Abstract][Full Text] [Related]
2. Importance of excision repair cross-complementation group 1 and ribonucleotide reductase M1 as prognostic biomarkers in malignant pleural mesothelioma treated with platinum-based induction chemotherapy followed by surgery.
Frischknecht L; Meerang M; Soltermann A; Stahel R; Moch H; Seifert B; Weder W; Opitz I
J Thorac Cardiovasc Surg; 2015 Jun; 149(6):1539-46.e1. PubMed ID: 25840756
[TBL] [
